Dante Rotili

54PUBLICATIONS
170CO-AUTHORS
Gene and molecular therapyCheminformatics and quantitative structure-activity relationshipsHaematological tumoursMolecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Jul 20, 2026
METTL1/WDR4 Complex: A Novel Epitranscriptomic Target at the Crossroads of RNA Methylation and Drug Discovery.

|May 05, 2026
Development of High-Affinity CHD1 Chromodomain Inhibitors.

|Apr 30, 2026
Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells.

|Jan 28, 2026
A Combined SIRT5 Activation and SIRT3 Inhibition Prevents Breast Cancer Spheroids Growth by Reducing HIF-1α and Mitophagy.

Federica Barreca, Michele Aventaggiato, Mario Cristina

|Dec 31, 2025
Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710.

Simona Sennato, Giorgia Paldino, Cecilia Bombelli

|Nov 27, 2025
A Feasibility Study of Co-Established Patient-Derived Subcutaneous Xenograft and Organotypic Slice Cultures in Hormone-Naive Primary Prostate Cancer Preclinical Modeling: A Single-Institution Experience.

Valeria Pecci, Melissa Borsa, Aurora Aiello

Pageof 9

Frequent Collaborators

42 joint publications

Antonello Mai

26 joint publications

Francesco Fiorentino

6 joint publications

Sergio Valente

5 joint publications

Lucia Altucci